C16orf89

chromosome 16 open reading frame 89

Basic information

Region (hg38): 16:5044122-5066110

Links

ENSG00000153446NCBI:146556HGNC:28687Uniprot:Q6UX73AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the C16orf89 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the C16orf89 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
1
clinvar
1
nonsense
0
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 2 0 0

Variants in C16orf89

This is a list of pathogenic ClinVar variants found in the C16orf89 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-5058503-C-T not specified Uncertain significance (Jul 12, 2024)3338919
16-5060315-GT-G not specified Uncertain significance (Jan 23, 2024)3063662
16-5062443-C-T not specified Uncertain significance (Aug 13, 2021)2372830
16-5065720-C-T not specified Likely benign (Jul 12, 2024)3338930

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
C16orf89protein_codingprotein_codingENST00000315997 821989
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.63e-160.0018012467701261248030.000505
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.512732111.290.00001202565
Missense in Polyphen6248.7621.2715639
Synonymous-1.4911293.71.200.00000566802
Loss of Function-0.8142218.31.218.68e-7199

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001480.00147
Ashkenazi Jewish0.002900.00288
East Asian0.0003370.000334
Finnish0.00004650.0000464
European (Non-Finnish)0.0002130.000212
Middle Eastern0.0003370.000334
South Asian0.0004910.000490
Other0.0006630.000660

dbNSFP

Source: dbNSFP

Intolerance Scores

loftool
0.880
rvis_EVS
0.8
rvis_percentile_EVS
87.66

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.123
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
AU021092
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
Cellular component
cytosol;membrane;extracellular exosome
Molecular function
protein homodimerization activity